Fecal microbiota transplantation for Clostridium difficile infection: benefits and barriers
Abstract
PURPOSE OF REVIEW: The incidence and severity of Clostridium difficile infection (CDI) have increased worldwide in the past two decades. A principal function of the gut microbiota is to protect the intestine against colonization by exogenous pathogens. Increasingly, the gut microbiota have been shown to influence susceptibility to other genetic and environmentally acquired conditions. Transplantation of healthy donor fecal material in patients with CDI may re-establish the normal composition of the gut microbiota and has been shown to be effective in recurrent CDI. We intend to review the most recent data on fecal microbiota transplantation (FMT) and critically discuss potential advantages and handicaps of this new therapeutic approach. RECENT FINDINGS: Evidence from case series and only one randomized clinical trial suggests that FMT is able to restore the wide diversity of microflora, improve C. difficile-related symptoms and prevent CDI recurrence. SUMMARY: FMT is a promising treatment option for serious and recurrent CDI, and current evidence (although weak) demonstrates consistent and excellent efficacy in clinical outcomes. However, many questions should be answered before it may be recommended as routine standard treatment. Mechanisms of action need to be better understood. Long-term follow-up studies are needed to determine long-lasting effects (including the association with autoimmune diseases).
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Taken together, these data indicate that FMT is a promising treatment option for serious and recurrent CDI.
“Taken together, these data indicate that FMT is a promising treatment option for serious and recurrent CDI [309,310]”
From Gut microbiota role in irritable bowel syndrome: New therapeutic strategies (2016) · cites this paper as [310]
Cites
Duodenal Infusion of Donor Feces for Recurrent <i>Clostridium difficile</i>
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708 · see citing works
Cohen, S. H., Gerding, D. N., Johnson, S., Kelly, C. P., Loo, V. G., McDonald, L. C., Pépin, J., & Wilcox, M. H. (2010) · Infection Control and Hospital Epidemiology · doi:10.1086/651706 · Cited by 2,931 · see citing works
Vrieze, A., Van Nood, E., Holleman, F., Salojärvi, J., Kootte, R. S., Bartelsman, J. F. W. M., Dallinga–Thie, G. M., Ackermans, M. T., Serlie, M. J., Oozeer, R., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.031 · Cited by 2,913 · see citing works
The interplay between the intestinal microbiota and the brain
Collins, S. M., Surette, M., & Bercik, P. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2876 · Cited by 1,611 · see citing works
Clostridium difficile infection in Europe: a hospital-based survey
Bauer, M. P., Notermans, D. W., BENTHEM, B. H. B. V., Brazier, J. S., Wilcox, M. H., Rupnik, M., Monnet, D. L., van Dissel, J. T., & Kuijper, E. J. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61266-4 · Cited by 1,014 · see citing works
Chang, J. Y., Antonopoulos, D. A., Kalra, A., Tonelli, A., Khalife, W. T., Schmidt, T. M., & Young, V. B. (2008) · The Journal of Infectious Diseases · doi:10.1086/525047 · Cited by 1,010 · see citing works
Treating Clostridium difficile infection with fecal microbiota transplantation
Bakken, J. S., Borody, T., Brandt, L. J., Brill, J. V., Demarco, D. C., Franzos, M. A., Kelly, C., Khoruts, A., Louie, T., Martinelli, L. P., et al. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.08.014 · Cited by 1,003 · see citing works
Gough, E., Shaikh, H., & Manges, A. R. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir632 · Cited by 1,003 · see citing works
Kassam, Z., Lee, C. H., Yuan, Y., & Hunt, R. H. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.59 · Cited by 904 · see citing works
The Changing Epidemiology of Clostridium difficile Infections
Freeman, J., Bauer, M. P., Baines, S. D., Corver, J., Fawley, W. N., Goorhuis, A., Kuijper, E. J., & Wilcox, M. H. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00082-09 · Cited by 825 · see citing works
Hamilton, M. J., Weingarden, A. R., Sadowsky, M. J., & Khoruts, A. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.482 · Cited by 738 · see citing works
Brandt, L. J., Aroniadis, O. C., Mellow, M., Kanatzar, A., Kelly, C., Park, T., Stollman, N., Rohlke, F., & Surawicz, C. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.60 · Cited by 672 · see citing works
Khoruts, A., Dicksved, J., Jansson, J. K., & Sadowsky, M. J. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181c87e02 · Cited by 649 · see citing works
Lawley, T. D., Clare, S., Walker, A. W., Stares, M. D., Connor, T. R., Raisen, C., Goulding, D., Rad, R., Schreiber, F., Brandt, C., et al. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002995 · Cited by 540 · see citing works
The role of microbiota in infectious disease
Stecher, B., & Hardt, W. (2008) · Trends in Microbiology · doi:10.1016/j.tim.2007.12.008 · Cited by 533 · see citing works
Mechanisms controlling pathogen colonization of the gut
Stecher, B., & Hardt, W. (2010) · Current Opinion in Microbiology · doi:10.1016/j.mib.2010.10.003 · Cited by 415 · see citing works
Clostridium difficile infection: epidemiology, risk factors and management
Ananthakrishnan, A. N. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.190 · Cited by 353 · see citing works
Sorg, J. A., & Sonenshein, A. L. (2010) · Journal of Bacteriology · doi:10.1128/jb.00610-10 · Cited by 332 · see citing works
Kim, J., Smathers, S. A., Prasad, P. A., Leckerman, K. H., Coffin, S. E., & Zaoutis, T. E. (2008) · PEDIATRICS · doi:10.1542/peds.2008-0469 · Cited by 319 · see citing works
Durable Alteration of the Colonic Microbiota by the Administration of Donor Fecal Flora
Grehan, M., Borody, T. J., Leis, S., Campbell, J., Mitchell, H. M., & Wettstein, A. R. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181e5d06b · Cited by 253 · see citing works
Fecal bacteriotherapy for recurrent Clostridium difficile infection
Bakken, J. (2009) · Anaerobe · doi:10.1016/j.anaerobe.2009.09.007 · Cited by 217 · see citing works
Clostridium difficile infection
Vedantam, G., Clark, A. E., Chu, M., McQuade, R., Mallozzi, M., & Viswanathan, V. K. (2012) · Gut Microbes · doi:10.4161/gmic.19399 · Cited by 210 · see citing works
Clostridium difficile infection: an update on epidemiology, risk factors, and therapeutic options
Lo Vecchio, A., & Zacur, G. M. (2012) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32834bc9a9 · Cited by 183 · see citing works
Self-citationBrandt, L. J. (2013) · The American Journal of Gastroenterology · doi:10.1038/ajg.2012.450 · Cited by 171 · see citing works
Colonization for the Prevention of Clostridium difficile Disease in Hamsters
Sambol, S. P., Merrigan, M. M., Tang, J. K., Johnson, S., & Gerding, D. N. (2002) · The Journal of Infectious Diseases · doi:10.1086/345676 · Cited by 165 · see citing works
Zipursky, J. S., Sidorsky, T., Freedman, C. A., Sidorsky, M. N., & Kirkland, K. B. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis809 · Cited by 164 · see citing works
Guo, B., Harstall, C., Louie, T., van Zanten, S. V., & Dieleman, L. A. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2012.05033.x · Cited by 134 · see citing works
Russell, G., Kaplan, J., Ferraro, M., & Michelow, I. C. (2010) · PEDIATRICS · doi:10.1542/peds.2009-3363 · Cited by 120 · see citing works
Review article: faecal transplantation therapy for gastrointestinal disease
Landy, J., Al-Hassi, H. O., McLaughlin, S. D., Walker, A. W., Ciclitira, P. J., Nicholls, R. J., Clark, S. K., & Hart, A. L. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04737.x · Cited by 100 · see citing works
The Case for Vancomycin as the Preferred Drug for Treatment ofClostridium difficileInfection
Bartlett, J. G. (2008) · Clinical Infectious Diseases · doi:10.1086/587654 · Cited by 91 · see citing works
Clostridium difficile is no longer just a nosocomial infection or an infection of adults
Pituch, H. M. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(09)70016-0 · Cited by 82 · see citing works
Merrigan, M. M., Sambol, S. P., Johnson, S., & Gerding, D. N. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(09)70017-2 · Cited by 70 · see citing works
Functions of intestinal microflora in children
Buccigrossi, V., Nicastro, E., & Guarino, A. (2012) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32835a3500 · Cited by 61 · see citing works
He, X., Tian, Y., Guo, L., et al. (2010) · Microbial Ecology · doi:10.1007/s00248-010-9708-4 · Cited by 38 · see citing works
Fecal microbiota transplantation for recurrent C difficile infection: Ready for prime time?
Agito, M. D., Atreja, A., & Rizk, M. K. (2013) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.80a.12110 · Cited by 29 · see citing works
Jiang, Z., Hoang, L. N., Lasco, T. M., Garey, K. W., & DuPont, H. L. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis1025 · Cited by 23 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Gut microbiota role in irritable bowel syndrome: New therapeutic strategies
Distrutti, E., Monaldi, L., Ricci, P., & Fiorucci, S. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i7.2219 · Cited by 320 · see citing works
Update of probiotics in human world: A nonstop source of benefactions till the end of time
Zommiti, M., Feuilloley, M. G. J., & Connil, N. (2020) · Microorganisms · doi:10.3390/microorganisms8121907 · Cited by 225 · see citing works
Fecal microbiota transplant as a potential treatment for Parkinson's disease – A case series
Segal, A., Zlotnik, Y., Moyal-Atias, K., Abuhasira, R., & Ifergane, G. (2021) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2021.106791 · Cited by 124 · see citing works
- Authors
- Lo Vecchio, A., & Cohen, M. B.
- Affiliations
- Cincinnati Children's Hospital Medical Center (US)
- ORCID
- Cohen, Mitchell B.
- Venue
- Current Opinion in Gastroenterology
- Published
- 2014-01
- Volume
- 30
- Issue
- 1
- Pages
- 47-53
- ISSN
- 0267-1379 (ISSN-L)
- OpenAlex
- W1979353822
- Cited by
- 27
- References
- 36
- Citations by year
- 2025: 1 · 2024: 1 · 2022: 1 · 2021: 3 · 2020: 1 · 2019: 1 · 2016: 4 · 2015: 6 · 2014: 9
- FWCI
- 0.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Opinion in Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- fecal microbiota transplantation, Clostridium difficile infection, recurrent Clostridium difficile infection, gut microbiota, microbiome diversity, mechanism of action, autoimmune disease, donor selection
- MeSH terms
- Enterocolitis, Pseudomembranous, Feces, Humans, Intestines, Recurrence, Tissue Transplantation, Treatment Outcome, Evidence-Based Medicine, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review